Neolactotetraosylceramide: A novel non-invasive urinary biomarker for bladder cancer
I. B. Moreira, C. Rossdam, J. Beimdiek, M. M. Vicente, J. Schmitz, A. Oberbeck, J. H. Braesen, H. Tezval, F. F. R. Buettner
This paper identifies neolactotetraosylceramide (nLc4) as a non-invasive urinary biomarker for bladder cancer, showing higher levels in cancer tissues and urine exosomes with high specificity.
bioRxiv · Aug 8, 2023 · PreprintCancer Biology